EC
EcoR1 Capital’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,265,101
| Closed | -$103M | – | 91 |
|
|
2022
Q1 | $103M | Sell |
3,265,101
-2,258,257
| -41% | -$71.3M | 3.22% | 10 |
|
|
2021
Q4 | $224M | Buy |
5,523,358
+400,999
| +8% | +$16.2M | 7.12% | 3 |
|
|
2021
Q3 | $179M | Buy |
5,122,359
+1,787,112
| +54% | +$62.3M | 6.21% | 4 |
|
|
2021
Q2 | $91.6M | Buy |
3,335,247
+1,139,355
| +52% | +$31.3M | 3.42% | 8 |
|
|
2021
Q1 | $61.7M | Hold |
2,195,892
| – | – | 2.73% | 13 |
|
|
2020
Q4 | $57M | Buy |
2,195,892
+385,892
| +21% | +$10M | 3.06% | 12 |
|
|
2020
Q3 | $31M | Hold |
1,810,000
| – | – | 2.21% | 18 |
|
|
2020
Q2 | $44.8M | Buy |
1,810,000
+1,517,900
| +520% | +$37.6M | 3.31% | 11 |
|
|
2020
Q1 | $4.05M | Sell |
292,100
-437,805
| -60% | -$6.08M | 0.42% | 35 |
|
|
2019
Q4 | $7.37M | Sell |
729,905
-24,600
| -3% | -$248K | 0.66% | 27 |
|
|
2019
Q3 | $6.87M | Sell |
754,505
-733,700
| -49% | -$6.68M | 0.87% | 20 |
|
|
2019
Q2 | $11.8M | Buy |
1,488,205
+498,059
| +50% | +$3.94M | 1.19% | 19 |
|
|
2019
Q1 | $12.4M | Sell |
990,146
-233,349
| -19% | -$2.91M | 1.14% | 19 |
|
|
2018
Q4 | $13.2M | Sell |
1,223,495
-1,012,892
| -45% | -$10.9M | 1.32% | 20 |
|
|
2018
Q3 | $31.2M | Hold |
2,236,387
| – | – | 2.81% | 10 |
|
|
2018
Q2 | $27.4M | Hold |
2,236,387
| – | – | 2.61% | 10 |
|
|
2018
Q1 | $34.5M | Buy |
+2,236,387
| New | +$34.5M | 3.46% | 10 |
|